Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric S Lander

Showing results (291-300 of 347) with videos related to

Pageof 35
Sort By:
Nature Genetics|February 12, 2013
Mutations causing medullary cystic kidney disease type 1 lie in a large VNTR in MUC1 missed by massively parallel sequencingAndrew Kirby, Andreas Gnirke, David B Jaffe, et al.
Nature|February 11, 2011
The genomic complexity of primary human prostate cancerMichael F Berger, Michael S Lawrence, Francesca Demichelis, et al.
Nature|March 16, 2018
Corrigendum: An immunogenic personal neoantigen vaccine for patients with melanomaPatrick A Ott, Zhuting Hu, Derin B Keskin, et al.
Cell|April 30, 2013
Punctuated evolution of prostate cancer genomesSylvan C Baca, Davide Prandi, Michael S Lawrence, et al.
JAMA|March 8, 2017
Association of Rare and Common Variation in the Lipoprotein Lipase Gene With Coronary Artery DiseaseAmit V Khera, Hong-Hee Won, Gina M Peloso, et al.
Nature|June 21, 2019
Large-scale chemical-genetics yields new M. tuberculosis inhibitor classesEachan O Johnson, Emily LaVerriere, Emma Office, et al.
Nature|April 14, 2017
Human knockouts and phenotypic analysis in a cohort with a high rate of consanguinityDanish Saleheen, Pradeep Natarajan, Irina M Armean, et al.
Cell|September 18, 2012
Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencingMarcin Imielinski, Alice H Berger, Peter S Hammerman, et al.
Nature|May 25, 2012
Melanoma genome sequencing reveals frequent PREX2 mutationsMichael F Berger, Eran Hodis, Timothy P Heffernan, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 17, 2014
Complementary genomic approaches highlight the PI3K/mTOR pathway as a common vulnerability in osteosarcomaJennifer A Perry, Adam Kiezun, Peter Tonzi, et al.
Pageof 35

Showing results (291-300 of 347) with videos related to

Sort By:
Pageof 35
Nature Genetics|February 12, 2013
Mutations causing medullary cystic kidney disease type 1 lie in a large VNTR in MUC1 missed by massively parallel sequencingAndrew Kirby, Andreas Gnirke, David B Jaffe, et al.
Nature|February 11, 2011
The genomic complexity of primary human prostate cancerMichael F Berger, Michael S Lawrence, Francesca Demichelis, et al.
Nature|March 16, 2018
Corrigendum: An immunogenic personal neoantigen vaccine for patients with melanomaPatrick A Ott, Zhuting Hu, Derin B Keskin, et al.
Cell|April 30, 2013
Punctuated evolution of prostate cancer genomesSylvan C Baca, Davide Prandi, Michael S Lawrence, et al.
JAMA|March 8, 2017
Association of Rare and Common Variation in the Lipoprotein Lipase Gene With Coronary Artery DiseaseAmit V Khera, Hong-Hee Won, Gina M Peloso, et al.
Nature|June 21, 2019
Large-scale chemical-genetics yields new M. tuberculosis inhibitor classesEachan O Johnson, Emily LaVerriere, Emma Office, et al.
Nature|April 14, 2017
Human knockouts and phenotypic analysis in a cohort with a high rate of consanguinityDanish Saleheen, Pradeep Natarajan, Irina M Armean, et al.
Cell|September 18, 2012
Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencingMarcin Imielinski, Alice H Berger, Peter S Hammerman, et al.
Nature|May 25, 2012
Melanoma genome sequencing reveals frequent PREX2 mutationsMichael F Berger, Eran Hodis, Timothy P Heffernan, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 17, 2014
Complementary genomic approaches highlight the PI3K/mTOR pathway as a common vulnerability in osteosarcomaJennifer A Perry, Adam Kiezun, Peter Tonzi, et al.
Pageof 35